X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Mid Caps & Small Caps buck trend
Mon, 2 Feb 01:30 pm

With sustained selling pressures, Indian stock markets continued to move southwards in the last two trading hours. Sectoral indices are trading mixed with realty and capital goods leading the gains while PSU, banking and oil and gas sectors are leading the losses.

BSE-Sensex is down 195 points and NSE-Nifty is trading 50 points down. BSE Mid Cap is trading up 0.5% and BSE Small Cap index is trading up by 0.78%. The rupee is trading at 61.75 to the US dollar.

Healthcare stocks are trading strong with Biocon Ltd and Ranbaxy Lab being the leading gainers. However, Dr Reddy's Lab continued to trade weak. According to a leading financial daily, Biotechnology major Biocon plans to spend 10% of its annual biopharma revenue on research and development in the next fiscal year. The company, which is pursuing R&D in both novel biologics as well as biosimilars (generic versions of biologic drugs), in various stages of trials, had spent around Rs 1.31bn on R&D in the previous fiscal year which was 6% of the biopharma sales. The stock opened at Rs 415 and is trading up by 2.34% on BSE.

Majority of the auto ancillary stocks are trading in the green with Amara Raja Batteries and Sona Koyo Steer being the leading winners. Battery manufacturer Exide Industries declared December quarter results for the year ending 2015. Net sales during the quarter were up by 19.7% YoY. The EBITDA margins improved by approx 70 bps leading to increase in the operating profits by 18.6% YoY. On the bottom line, the company has reported a 25.42% YoY growth in its net profit for the quarter.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Mid Caps & Small Caps buck trend". Click here!

  

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS